CS1-BCMA CAR-T cells induced an ORR of 100%, a sCR rate of 46%, MRD-negativity of 100%, 1-year OS and PFS of 72.73% and 56.26%, respectively, in the 13 treated patients with MM cells in their BM. This evidence concerns the gene SLAMF7 and Miyoshi myopathy.